Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBSCT and CBV Preparative Therapy in Recurrent/Refractory Pediatric Lymphoma
NCT00002941Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Apr 1998
- Primary completion
- Nov 2002
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of carmustine, cyclophosphamide, etoposide in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Children's Oncology Group. Started Apr 1998; status: completed.
02
Drugs
carmustinecyclophosphamideetoposide
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00002941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002941.